The National Organization for Rare Disorders (NORD®) is honoring a distinguished group of industry leaders and individuals for their contributions to help improve the lives of more than 30 million ...

The function of the various subclasses of IgG molecules is mediated by the family of Fc receptors for IgG (FcγRs). This Review outlines how FcγRs regulate immune responses and the relevance of ...

Nipocalimab's FDA approval revolutionizes generalized myasthenia gravis treatment, offering rapid symptom relief and improved ...

The safety update for Vyvgart rattled argenx’s shares on Monday, a reaction that analysts at William Blair said was “overdone ...

Catalio Capital Management has closed its fourth venture fund with more than $400 million that will be used in part to launch two new companies.  | Catalio Capital Management has closed its fourth ...

A team of physicians recently reported the successful treatment of refractory autoimmune neuropathies through the infusion of autologous anti-CD19 CAR T-cells.

Mirima Freimer, MD, delves into potential reasons behind the longer-term efficacy of zilucoplan and also speaks to the treatment’s safety profile.

During early drug development and preclinical development, researchers use in vitro cultured lymphocytes to induce cytokine ...

The EC has approved argenx’s Vyvgart (efgartigimod alfa) 1000mg as a single agent for subcutaneous injection to treat CIDP.

This useful study employs optogenetics, genetically-encoded dopamine and serotonin sensors, and patch-clamp electrophysiology to investigate modulations of neurotransmitter release between striatal ...

BeOne Medicines has secured approval from the EC for Tevimbra (tislelizumab) to be used along with gemcitabine and cisplatin to treat NPC.

Fc receptors: A classification and overview FcRn and its role as a therapeutic target Feeder-cell alternatives for large-cell iPSC manufacturing FGL1 Protein Characterization for Cancer Detection ...